Non-invasive endothelial function assessment in patients with neurofibromatosis type 1: a cross-sectional study

Table 2 Blood test results of the participants in the NF1 and control groups

Blood test	NF1	Controls	P
Total cholesterol – mg/dL	168 ± 35	182 ± 36	0.137
LDL cholesterol – mg/dL	99 ± 28	107 ± 30	0.309
HDL cholesterol – mg/dL	53 ± 12	58 ± 13	0.169
VLDL cholesterol – mg/dL	15 ± 7	17 ± 6	0.369
Triglycerides – mg/dL	78 ± 36	85 ± 34	0.452
Fasting glycaemia – mg/dL (70–99)*	83 ± 5	81 ± 5	0.169
Serum creatinine – mg/dL (0.4-1.3)*	0.66 ± 0.13	0.77 ± 0.14	0.005
Serum urea – mg/dL (15–40)*	27 ± 8	26 ± 7	0.768
AST - U/L (4 – 38)*	21 ± 6	26 ± 5	0.001
ALT - U/L (4 – 38)*	20 ± 19	20 ± 9	0.907
Serum total bilirubin – mg/dL (up to 1.2)*	0.75 ± 0.52	0.75 ± 0.35	0.986
Direct bilirubin – mg/dL (up to 0.4)*	0.28 ± 0.10	0.30 ± 0.11	0.432
Indirect bilirubin – mg/dL	0.49 ± 0.48	0.45 ± 0.28	0.703
Prothrombin activity - % (70–100)*	84 ± 13	90 ± 7	0.034
TSH - mcIU/mL (0.44 – 4.48)*	1.77 ± 0.89	1.67 ± 0.76	0.649
Free T4 - ng/dL (0.8 – 1.9)*	1.29 ± 0.17	1.16 ± 0.16	0.006
Hemoglobin – g/dL (12–18)*	14.1 ± 1.2	14.4 ± 1.1	0.298
Hematocrit - % (35–52)*	41.5 ± 3.4	42.0 ± 2.9	0.499
WBC count -/mm³ (4,000-11,000)*	6,933 ± 1,924	5,798 ± 1,438	0.013
Platelet count -/mm³ (140,000-450,000)*	262,758 ± 61,586	250,620 ± 62,143	0.458

ISSN: 1471-2261